Relay Therapeutics Inc (NASDAQ: RLAY) is -33.97% lower on its value in year-to-date trading and has touched a low of $5.70 and a high of $13.32 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The RLAY stock was last observed hovering at around $7.34 in the last trading session, with the day’s loss setting it -0.07%.
Currently trading at $7.27, the stock is 8.12% and 6.61% above its SMA20 and SMA50 respectively. However, with a daily trading volume of 1.63 million and changing -0.95% at the moment leaves the stock -15.62% off its SMA200. RLAY registered -38.18% loss for a year compared to 6-month loss of -14.57%.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The stock witnessed a 7.86% gain in the last 1 month and extending the period to 3 months gives it a -28.37%, and is 15.40% up over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 8.08% over the week and 7.50% over the month.
Relay Therapeutics Inc (RLAY) has around 323 employees, a market worth around $965.02M and $35.33M in sales. Profit margin for the company is -931.62%. Distance from 52-week low is 27.54% and -45.42% from its 52-week high. The company has generated returns on investments over the last 12 months (-41.51%).
The EPS is expected to shrink by -1.26% this year
The shares outstanding are 127.46M, and float is at 91.19M with Short Float at 13.03%.
Relay Therapeutics Inc (RLAY) Insider Activity
The most recent transaction is an insider sale by Rahmer Peter,. SEC filings show that Rahmer Peter sold 20,450 shares of the company’s common stock on Jun 05 ’24 at a price of $7.06 per share for a total of $0.14 million. Following the sale, the insider now owns 0.43 million shares.
Relay Therapeutics Inc disclosed in a document filed with the SEC on Jun 04 ’24 that Rahmer Peter sold a total of 40,595 shares of the company’s common stock. The trade occurred on Jun 04 ’24 and was made at $6.64 per share for $0.27 million. Following the transaction, the insider now directly holds 0.45 million shares of the RLAY stock.
Still, SEC filings show that on Jun 03 ’24, Rahmer Peter disposed off 19,864 shares at an average price of $6.47 for $0.13 million. The insider now directly holds 493,470 shares of Relay Therapeutics Inc (RLAY).
